Coherus Oncology, Inc.CHRSNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank38
3Y CAGR-34.8%
5Y CAGR-15.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-34.8%/yr
vs +35.3%/yr prior
5Y CAGR
-15.7%/yr
Recent deceleration
Acceleration
-70.1pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.00M | -66.9% |
| 2024 | $27.16M | -33.0% |
| 2023 | $40.54M | +24.8% |
| 2022 | $32.47M | +41.4% |
| 2021 | $22.96M | +8.5% |
| 2020 | $21.17M | +20.3% |
| 2019 | $17.60M | +81.8% |
| 2018 | $9.68M | +1.4% |
| 2017 | $9.55M | +19.7% |
| 2016 | $7.98M | - |